28 October 2019
The Centre for Medicine Use and Safety is looking for a PhD scholar that will be based at the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University (Parkville).
The National Health and Medical Research Council (NHMRC), as part of the Boosting Dementia Research Grants Priority Round Five: Dementia Risk Reduction and Prevention, which awarded $2 million to Monash University for a study designed to prevent and reduce the risk of developing dementia in 45-65-year-old adults.
The program – called Holistic Approach in Primary care for Preventing Memory Impairment and Dementia (HAPPI MIND) – will be carried out across New South Wales and Victoria with a view to developing an individualised health promotion programme, comprising of self-management training, practical behaviour change techniques and GP-coordinated interdisciplinary management of dementia risk factors The collaborative interdisciplinary project involving Monash University, Melbourne University, Deakin University and the University of Newcastle is led by Dr Johnson George, Centre for Medicine Use and Safety (CMUS) at the Monash Institute of Pharmaceutical Sciences.
The program will involve three-monthly face-to-face or telephone meetings with the practice nurse, a personalised risk reduction action plan, and referral to targeted additional interventions as needed in 1st year and tailored mobile phone-based risk reduction.
For further information, visit the Monash University website.
For project-related enquiries please contact Dr Johnson George (Principal Investigator) by email: Johnson.George@monash.edu
By the Centre for Medicine Use and Safety.